have you seen any evidence they are? All I know about is the cd54 stuff and some briefing documents that suggest they can't pinpoint the in-vivo target. Maybe they have a secret effort but I'd consider that to be material information :) Instead of the regulatory actions, I'd be more worried about disclosure of things like this, " we conclusively proved it can't work the way it was designed to work." Don't you think that would be just as important as an inspector finding an ungrounded coffee maker? ( I just made that up, it isn't a refernce to anything to indicate range of regulatory concerns). LOL.
Market Data 
Markets 
AI
